Navigation Links
HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
Date:11/9/2010

FRAMINGHAM, Mass. and SYDNEY, Nov. 9, 2010 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that Keith Aaronson, MD, MS, will present data from the ADVANCE Bridge-to-Transplant clinical trial on Sunday, November 14, at the American Heart Association (AHA) Scientific Sessions 2010 at McCormick Place in Chicago.  Dr. Aaronson, Associate Professor in the Division of Cardiovascular Medicine and Medical Director of the Heart Transplant Program and Center for Circulatory Support at the University of Michigan, is a principal investigator of the ADVANCE trial.

The formal presentation, entitled Evaluation of the HeartWare® HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge-to-Transplant Trial, is scheduled for approximately 4:00 p.m. CST in Hall B.  

Following that presentation, HeartWare will host an investor meeting with CEO Doug Godshall, Dr. Aaronson and Mark Slaughter, MD, to review the trial data at 6:30 p.m. CST (7:30 p.m. EST).  Dr. Slaughter is Professor and Chief in the Division of Thoracic and Cardiovascular Surgery and Director of the Mechanical Assist Device and Heart Transplant Program at the University of Louisville in Louisville, Kentucky, and is also a principal investigator for the ADVANCE trial.

An audio feed of the event will be available to the public via webcast through the Company's website at www.heartware.com by selecting "Bridge-to-Transplant Data Investor Meeting" under the section titled "Corporate Presentations" on the Home Page.  A replay of the webcast will be available through the above weblink shortly foll
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. HeartWare to Report Financial Results for Third Quarter of 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
11. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
(Date:5/23/2013)... , May 23, 2013  The need to ... treatment continuum was highlighted prominently at the 108 ... Association (AUA), in San Diego.  According to SonaCare ... focused ultrasound (HIFU) technology, the need for image-guided ... for urologists to consider minimally invasive ablative treatments, ...
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... 2012 /PRNewswire-iReach/ -- Precision Antibody, ... announced today that they have expanded their ... RED96™ system, a multi-functional, label-free, real-time binding ... Antibody has been providing antibody characterization services ...
... 2012 In a historic open letter to ... the Coalition for Mercury-Free Drugs (CoMeD) , and the United ... in human drugs, especially vaccines.  Currently, the mercury-based preservative Thimerosal, ... the United States and much of the world, despite the ...
Cached Medicine Technology:Precision Antibody Expands Antibody Characterization Services 2Global Call for Mercury-free Vaccines Issued 2
(Date:5/24/2013)... ResortQuest Real Estate® is proud to ... team at the firm’s Bethany Beach location. , Originally ... home in 1975. Her real estate career began in ... of the real estate business - receptionist, cleaning coordinator, ... a licensed sales associate. , “I am delighted ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- New research ... thoughts among people with insomnia. Every additional ... a 72 percent drop in the likelihood of ... researchers from the University of Pennsylvania. ... association between sleep duration and suicide risk," study ...
(Date:5/24/2013)... (HealthDay News) -- Drugs commonly used to treat glaucoma ... can interfere with vision, according to a new study. ... are used to reduce eye pressure, have already been ... eye color, the researchers said, suggesting that the new ... Doctors should be conservative when prescribing these drugs, ...
(Date:5/24/2013)... Area homeowners dreaming about owning a hot tub ... choose from at factory-direct pricing during the Jacuzzi Hot ... place at Emerald Pool and Patio in Bend, ... industry's leading hot tub brand, scheduled the event as part ... will feature popular hot tub models at up to 50% ...
(Date:5/24/2013)... infantile myofibromatosis (IM)a disorder characterized by multiple tumors involving ... targets, according to researchers from the Icahn School of ... American Journal of Human Genetics , may lead ... which the only current treatment option is repeated surgical ... disorder that develops in infancy or even in utero ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
... Group led by conservative political operative with ties to convicted ... Public Campaign Action Fund issued a new investigative report today ... group behind the political ads, currently running in eight states, ... Americans for Prosperity Foundation, which has a record as a ...
... ARBOR, Mich. University of Michigan scientists have found that a ... to the most common type of adult brain cancer. The study, ... more effective future treatments and a way to screen for the ... the U-M team,s findings in mice show for the first time ...
... Arlen Specter (D-Pa.) and John Cornyn (R-Tex.) will speak ... and services during the American Association for Homecare Washington ... , , During the week, homecare ... fundamental reforms to Medicare policy for durable medical equipment ...
... a difficult-to-treat form of childhood epilepsy called infantile spasms ... with features closely resembling those occurring in patients with ... opportunity for scientists to test treatments that may benefit ... every 100 infants has a seizure. Many of them ...
... the field of addiction treatment administration and management presented ... National Association of Addiction Treatment Providers. , , ... held National Association of Addiction Treatment Providers annual leadership ... where the American College of Addiction Treatment Administrators presented ...
... June 1 Using a lawn mower can be as routine ... often, people find themselves in terrifying situations with these seemingly safe ... children - are injured in lawn mower-related accidents each year, the ... "attack" on their own. Most injuries - such as severed ...
Cached Medicine News:Health News:'Viewers Beware' Report By Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running In Eight States 2Health News:Most common brain cancer may originate in neural stem cells 2Health News:Most common brain cancer may originate in neural stem cells 3Health News:Most common brain cancer may originate in neural stem cells 4Health News:Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009 2Health News:Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009 3Health News:Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 2Health News:Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 3Health News:Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants 4Health News:Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA) 2Health News:Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA) 3Health News:When Lawn Mowers Attack: National Medical Societies Offer Tips to Prevent Injuries; Children Often Victims 2Health News:When Lawn Mowers Attack: National Medical Societies Offer Tips to Prevent Injuries; Children Often Victims 3Health News:When Lawn Mowers Attack: National Medical Societies Offer Tips to Prevent Injuries; Children Often Victims 4
... When post-op care demands the best, the ... from 22" to 34" (56 cm to 86 ... cm) in leg circumference, this brace easily fits ... (196 cm) tall, and adapts as the patient ...
... Lock Knee Brace is designed to ... the arthroscopic ACL reconstruction. The levers ... rehabilitation or passive motion exercise, but ... full extension for ambulation or sleeping. ...
The Bledsoe Adjustable Knee Brace is designed to meet the most stringent demands of post-op care. When post-op care demands the best, the Bledsoe Adjustable Knee Brace is the physicians' preferred ch...
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
Medicine Products: